Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1486044Generated: October 30, 2026

Sodium Iodide → tert-butyl(S)-1-((3S,4S)-1-((2-methoxynaphthalen-1-yl)methyl)-4-methyl-2-oxo-5-(tetrahydro-2H-pyran-4-carbonyl)-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate

https://huagongshe.com/reaction/1486044

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSodium IodideHCID 5238—
ReactantCesium carbonateHCID 10796—
Reactant1-(Chloromethyl)-2-methoxynaphthaleneHCID 13356646—
Reactanttert-butyl methyl((S)-1-((2S,3S)-2-methyl-4-oxo-1-(tetrahydro-2H-pyran-4-carbonyl)-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl)carbamateHCID 90082481—
SolventDimethylformamideHCID 6228—
SolventEthyl AcetateHCID 8857—
Producttert-butyl(S)-1-((3S,4S)-1-((2-methoxynaphthalen-1-yl)methyl)-4-methyl-2-oxo-5-(tetrahydro-2H-pyran-4-carbonyl)-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamateHCID 11829263652.2%

Reaction Steps

To a room temperature solution of tert-butyl methyl((S)-1-((2S,3S)-2-methyl-4-oxo-1-(tetrahydro-2H-pyran-4-carbonyl)-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl)carbamate (prepared as in Example RK-1, Step 3, 75 mg, 154 μmol) in N,N-dimethylformamide (500 μl) was added 1-(chloromethyl)-2-methoxynaphthalene (38 mg, 184 μmol), cesium carbonate (65 mg, 200 μmol), and sodium iodide (30 mg, 200 μmol). The reaction was stirred at room temperature for 16 h. After this time, the reaction mixture was diluted with ethyl acetate (20 mL), washed with water (20 mL) the aqueous layer was then extracted with ethyl acetate (2×20 mL) and the organic layers combined and then washed with a saturated aqueous sodium chloride solution (30 mL), dried over magnesium sulfate, filtered, and the filterate concentrated in vacuo. The crude material was purified by flash chromatography to afford tert-butyl(S)-1-((3S,4S)-1-((2-methoxynaphthalen-1-yl)methyl)-4-methyl-2-oxo-5-(tetrahydro-2H-pyran-4-carbonyl)-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-ylamino)-1-oxopropan-2-yl(methyl)carbamate (53 mg, 52%) as a light yellow foam: LC-MS m/z 681 [M+Na]+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09422331B2
Source datasetuspto-grants-2016_08
ORD IDord-3f1f5a0468cf4b68bc3939b9ceb39967
Source noteuspto-grants-2016_08